Scientists engineer mosquitoes to vaccinate victims

Japanese researchers have genetically modified an Anopheles mosquito, a carrier of malaria, to produce a natural vaccine protein in its saliva that would be introduced into a person's bloodstream whenever it bites. The prototype of the insect also carries a vaccine against Leishmania, a potentially deadly parasitic disease carried by sand flies. The method could raise ethical questions because it would entail a kind of mass vaccination without obtaining people's permission or tracking dosages, the lead researcher said.

View Full Article in:

Telegraph (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX